Acumen Pharmaceuticals
IPOPublic · Charlottesville, United States · Founded 2016 · $35.8M raised
- Headquarters
- Charlottesville, Virginia
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B
- Website
- acumenpharm.com
- Total Funding
- $35.8M
- Last Round
- $35.8M Private EquityMar 2026
- Rounds
- 1
- Type
- Public
About
Clinical-stage biopharmaceutical company developing targeted therapies for Alzheimer's disease focused on toxic amyloid beta oligomers.
Summary
Acumen Pharmaceuticals is a Biotech company based in Charlottesville, United States, founded in 2016. It has raised $35.8M in total across 1 round, most recently a $35.8M Private Equity round in Mar 2026. Investors include Public offering, RA Capital Management and ADAR1 Capital.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2026
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...